Author:
Scott Colleen,Walusimbi Simon,Kirenga Bruce,Joloba Moses,Winters Muttamba,Abdunoor Nyombi,Bain Rommel,Alexander Heather,Shinnick Tom,Toney Sean,Odeke Rosemary,Mwangi Christine,Birabwa Estella,Dejene Seyoum,Mugabe Frank,YaDiul Mukadi,Cavanaugh J. Sean
Publisher
Centers for Disease Control MMWR Office
Subject
Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health(social science),Epidemiology
Reference10 articles.
1. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.;Steingart;Cochrane Database Syst Rev,2014
2. World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children. Policy update. Geneva, Switzerland: World Health Organization; 2013.http://who.int/tb/laboratory/xpert_policyupdate/en/
3. Introducing new tuberculosis diagnostics: the impact of Xpert(®) MTB/RIF testing on case notifications in Nepal.;Creswell;Int J Tuberc Lung Dis,2015
4. Joint United Nations Programme on HIV/AIDS. HIV and AIDS estimates. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2015. http://www.unaids.org/en/regionscountries/countries/uganda
5. Uganda Bureau of Statistics. Uganda National Population and Housing Census 2014 provisional results: November 2014. Kampala, Uganda: Uganda Bureau of Statistics; 2014. https://unstats.un.org/unsd/demographic/sources/census/wphc/Uganda/UGA-2014-11.pdf